Sorrento Stock Deal Emerges Days Before It Runs Out of Cash
(Bloomberg) — Sorrento Therapeutics Inc., which filed for bankruptcy in February after suffering shortseller attacks for prematurely saying it had developed a cure for Covid-19, received court approval to sell a major stake in its publicly traded subsidiary.
Most Read from Bloomberg
The San Diego-based company is set to sell its shares of Scilex Holding Co. back to Scilex after a previous deal fell through last-minute, according to court papers. Under the agreement, Scilex will pay Sorrento…